Other languages SI-BONE, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
14.03 ^USD	-0.14%		-7.15%	-33.16%

May. 14	Transcript : SI-BONE, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
May. 07	Morgan Stanley Trims Price Target on SI-Bone to $25 From $26, Keeps Overweight Rating	MT

SI-BONE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06
Si-Bone, Inc. Increases Revenue Guidance for 2024	May. 06
SI-BONE, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 26
SI-BONE, Inc. Provides Earnings Guidance for the Year 2024	Feb. 26
Si-bone Insider Sold Shares Worth $808,591, According to a Recent SEC Filing	Feb. 21
SI-Bone Implant Receives Expanded FDA Approval	Jan. 30
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	Jan. 30
SI-Bone, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	Jan. 08
SI-BONE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06
SI-BONE, Inc. Increases Earnings Guidance for the Full Year 2023	Nov. 06
Si-bone Insider Sold Shares Worth $423,738, According to a Recent SEC Filing	23-10-04
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera 5.5/6.0 System Rods	23-09-05
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-15
SI-BONE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
SI-BONE, Inc. Revises Revenue Guidance for the Year 2023	23-08-07
Insider Sell: Si-bone	23-05-18
Insider Sell: Si-bone	23-05-18

No results for this search